John Teasley
ON THE RECORD · 4 verbatim quotes · every quote source-verified
“We're seeing a medication class with the potential to reshape how providers generate revenue, where investors allocate capital, and how consumers engage with their health.”
John Teasley · said date not stated · reported 2026-08-20
John Teasley outlined how GLP-1 medications could alter healthcare revenue, capital allocation, and consumer health engagement.
“The biggest takeaway from our research isn't that healthcare is shrinking, it's that healthcare is being rewired,”
John Teasley · said date not stated · reported 2026-08-20
John Teasley summarized the key finding of the research regarding the structural rewiring of the healthcare industry.
“Obesity therapies have already taken cancer as the pharmaceutical industry's leading area of investment, reflecting growing confidence that these treatments could improve the health of millions of Americans while fundamentally reshaping one of the country's largest industries,”
John Teasley · said date not stated · reported 2026-08-20
John Teasley noted that obesity therapies have overtaken oncology as the leading investment area for the pharmaceutical industry.
“GLP-1s may be marketed as weight-loss drugs, but they're rapidly becoming one of the most disruptive economic forces in healthcare,”
John Teasley · said date not stated · reported 2026-08-20
John Teasley commented on the disruptive economic impact of GLP-1 weight-loss drugs across the healthcare sector.